𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retinoic acid: Topical treatment of senile or actinic keratoses and basal cell carcinomas

✍ Scribed by W. Bollag; F. Ott

Book ID
105417059
Publisher
SP Birkhäuser Verlag Basel
Year
1970
Tongue
English
Weight
371 KB
Volume
1
Category
Article
ISSN
1420-908X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of topical tubercidin on basal ce
Effect of topical tubercidin on basal cell carcinomas and actinic keratoses
✍ Gordon H. Burgess; Alexander Bloch; Howard Stoll; Halena Milgrom; Frederick Helm 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 1 views

The nucleoside Tubercidin was applied topically in a 0.5% concentration to solitary basal cell carcinomas in eight patients and widespread actinic keratoses in five patients for periods of 2-6 weeks. The treatment resulted in complete resolution of all eight basal cell carcinomas. All patients have

13-CIS retinoic acid and interferon-α ±
13-CIS retinoic acid and interferon-α ± irradiation in the treatment of squamous-cell carcinomas
✍ Wolfgang Hoffmann; Martina Schiebe; Peter Hirnle; Rainer Souchon; Michael Clemen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 43 KB 👁 1 views

Pre-clinical data indicate that retinoid/interferon combinations have significant activity in modulating malignant cell growth, differentiation and programmed cell death in different hematologic and solid tumor systems . Clinically, the combination of 13-cis retinoic acid (13cRA) and interferon-a (I

Phase I trial of interferon α2b and lipo
Phase I trial of interferon α2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma
✍ Jonathan S. Goldberg; Manuel Vargas; Alyssa S. Rosmarin; Matthew I. Milowsky; Ni 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Abstract ## BACKGROUND Studies suggest that retinoic acid (RA) can augment the antitumor effects of interferon‐based therapy in patients with advanced renal cell carcinoma (RC); however, this benefit has not been achieved convincingly using oral formulations of 13‐cis RA and all‐__trans__ RA. L